May 2006
Volume 47, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2006
Lensectomy and Vitrectomy With and Without Intravitreal Triamcinolone Acetonide for Vascularly Active Stage 5 Retinal Detachments in Retinopathy of Prematurity
Author Affiliations & Notes
  • J.A. Fortun
    Department of Ophthalmology, Baylor College of Medicine, Houston, TX
  • R.R. Lakhanpal
    Department of Ophthalmology, Baylor College of Medicine, Houston, TX
  • E.R. Holz
    Department of Ophthalmology, Baylor College of Medicine, Houston, TX
  • Footnotes
    Commercial Relationships  J.A. Fortun, None; R.R. Lakhanpal, None; E.R. Holz, None.
  • Footnotes
    Support  Unrestricted grant from Research to Prevent Blindness, Inc., New York, NY
Investigative Ophthalmology & Visual Science May 2006, Vol.47, 5323. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      J.A. Fortun, R.R. Lakhanpal, E.R. Holz; Lensectomy and Vitrectomy With and Without Intravitreal Triamcinolone Acetonide for Vascularly Active Stage 5 Retinal Detachments in Retinopathy of Prematurity . Invest. Ophthalmol. Vis. Sci. 2006;47(13):5323.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To determine the anatomic success rate of lensectomy and vitrectomy with and without intravitreal triamcinolone acetonide for vascularly active Stage 5 tractional retinal detachments due to Retinopathy of Prematurity (ROP).

Methods: : In a retrospective, interventional, single–surgeon, consecutive case series, the records of 21 eyes of 21 patients presenting with stage 5 retinal detachment secondary to ROP that underwent a primary pars plicata vitrectomy with lensectomy from February 1998 to January 2004 were evaluated. All eyes were vascularly active at the time of surgery. Eleven eyes underwent the surgical procedure without intravitreal injection of triamcinolone acetonide (group 1) and 10 eyes received intravitreal medication at the end of the procedure (group 2). The main outcome measure, retinal reattachment, was reviewed at final follow–up visit, which ranged from 6 to 42 months (mean, 28 months) after surgery.

Results: : Two eyes, one from each group, had documented intraoperative tears during surgery, remained detached during follow–up, and were excluded from the study. None of the eyes in group 1 maintained attachment while 6 of 9 eyes in group 2 (66.7%) maintained at least posterior pole reattachment at final visit. None of the group 2 eyes exhibited plus disease during follow–up. None of the eyes in either group exhibited signs of increased intraocular pressure after surgery.

Conclusions: : Vascularly active stage 5 ROP detachments portend a poor prognosis. The use of intravitreal triamcinolone acetonide as a postoperative adjunct may improve the likelihood of retinal reattachment in these selected cases.

Keywords: retinopathy of prematurity • vitreoretinal surgery • macula/fovea 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×